Kawar
Gaith Kawar, Redwood City, CA US
Patent application number | Description | Published |
---|---|---|
20150348073 | Predictive Tool for Defining Target Group - Embodiments relate to methods and apparatuses creating and analyzing target groups, for example as relied upon in conducting marketing campaigns. Certain embodiments allow predictive definition of a target group based upon an underlying complex mathematical model, which may reference large data volumes regarding individual targets in an underlying database. An interface affords simplified visualizations of the target group, for example circles of varying diameter representing target group size. Adjustable graphic elements (e.g., sliders) in dashboard views may allow predictive definition of the target group based upon inputs such as marketing cost, target group size, and/or expected revenue, etc. Once defined and stored, target groups may be explored in an interactive manner through application of filter criteria, thereby promoting familiarity with target group characteristics. Embodiments allow users who are not modeling experts, to nevertheless interact efficiently with large data volumes in order to intuitively define and/or explore a target group. | 12-03-2015 |
20150348124 | Interactive Tool for Exploring Target Group - Embodiments relate to methods and apparatuses creating and analyzing target groups, for example as relied upon in conducting marketing campaigns. Certain embodiments allow predictive definition of a target group based upon an underlying complex mathematical model, which may reference large data volumes regarding individual targets in an underlying database. An interface affords simplified visualizations of the target group, for example circles of varying diameter representing target group size. Adjustable graphic elements (e.g., sliders) in dashboard views may allow predictive definition of the target group based upon inputs such as marketing cost, target group size, and/or expected revenue, etc. Once defined and stored, target groups may be explored in an interactive manner through application of filter criteria, thereby promoting familiarity with target group characteristics. Embodiments allow users who are not modeling experts, to nevertheless interact efficiently with large data volumes in order to intuitively define and/or explore a target group. | 12-03-2015 |
Kristen Elserougi Kawar US
Patent application number | Description | Published |
---|---|---|
20110320998 | LIGHT-EMITTING DIODE SYSTEM DESIGNER - A system may include a database configured to store information including characteristics of a plurality of components. The system may further include a server in communication with the database and configured to receive design parameters indicative of characteristics of an LED lighting solution; determine a plurality of LED lighting array designs, each design including at least one of a parallel and a series arrangement of LEDs and configured to provide an amount of light specified by the design parameters; for each one of at least a subset of the plurality of LED lighting array designs, determine an LED driver design configured to power the one of the LED lighting array designs; and generate at least one LED lighting solution, each LED lighting solution including one of the LED lighting array designs combined with one of the LED driver designs configured to power the one of the LED lighting arrays. | 12-29-2011 |
Ziad S. Kawar, Oklahoma City, OK US
Patent application number | Description | Published |
---|---|---|
20110212096 | ANTI-P-SELECTIN ANTIBODIES AND METHODS OF THEIR USE AND IDENTIFICATION - Antibodies are disclosed which bind specifically to P-selectin and which block the binding of PSGL-1 to P-selectin. These anti-P-selectin antibodies may also cause dissociation of preformed P-selectin/PSGL-1 complexes. The disclosure identifies a heretofore unrecognized, near N-terminal, antibody binding domain (a conformational epitope) of P-selectin to which the function-blocking antibodies (which may be chimeric, human or humanized antibodies for example) bind. Antibodies are disclosed which bind to the conformational epitope of P-selectin and which have a dual function in blocking binding of PSGL-1 to P-selectin, and in causing dissociation of preformed P-selectin/PSGL-1 complexes. Such single and dual function anti-P-selectin antibodies and binding fragments thereof may be used in the treatment of a variety of inflammatory and thrombotic disorders and conditions. Screening methods for identifying such antibodies are also disclosed. | 09-01-2011 |
20110287017 | ANTI-P-SELECTIN ANTIBODIES AND METHODS OF THEIR USE AND IDENTIFICATION - Antibodies are disclosed which bind specifically to P-selectin and which block the binding of PSGL-1 to P-selectin. These anti-P-selectin antibodies may also cause dissociation of preformed P-selectin/PSGL-1 complexes. The disclosure identifies a heretofore unrecognized, near N-terminal, antibody binding domain (a conformational epitope) of P-selectin to which the function-blocking antibodies (which may be chimeric, human or humanized antibodies for example) bind. Antibodies are disclosed which bind to the conformational epitope of P-selectin and which have a dual function in blocking binding of PSGL-1 to P-selectin, and in causing dissociation of preformed P-selectin/PSGL-1 complexes. Such single and dual function anti-P-selectin antibodies and binding fragments thereof may be used in the treatment of a variety of inflammatory and thrombotic disorders and conditions. Screening methods for identifying such antibodies are also disclosed. | 11-24-2011 |
20110293617 | ANTI-P-SELECTIN ANTIBODIES AND METHODS OF THEIR USE AND IDENTIFICATION - Antibodies are disclosed which bind specifically to P-selectin and which block the binding of PSGL-1 to P-selectin. These anti-P-selectin antibodies may also cause dissociation of preformed P-selectin/PSGL-1 complexes. The disclosure identifies a heretofore unrecognized, near N-terminal, antibody binding domain (a conformational epitope) of P-selectin to which the function-blocking antibodies (which may be chimeric, human or humanized antibodies for example) bind. Antibodies are disclosed which bind to the conformational epitope of P-selectin and which have a dual function in blocking binding of PSGL-1 to P-selectin, and in causing dissociation of preformed P-selectin/PSGL-1 complexes. Such single and dual function anti-P-selectin antibodies and binding fragments thereof may be used in the treatment of a variety of inflammatory and thrombotic disorders and conditions. Screening methods for identifying such antibodies are also disclosed. | 12-01-2011 |